The History of NFID (Part II)

…continued from The History of NFID (Part I)

Once we had an official logo, we then created a monthly newsletter, “The Double Helix,” to inform as many people as possible what NFID was all about. As time passed, the newsletter proved to be very successful.

In 1973, Jack left the Medical College of Virginia (MCV) to become Dean of the School of Medicine at Georgetown University; and shortly after his departure, I replaced him as Chair of the Infectious Disease Division at MCV.

By 1975, NFID was beginning to make headway. President Utz testified on behalf of NFID before the Senate Committee on Appropriations in support of the National Institute of Allergy and Infectious Disease (NIAID). Four years later in 1979, both Dr. Utz and I testified together regarding federal support for NIAID. In both of these instances, we felt that we were successful in making a difference.

Our Board of Directors continued to grow rapidly, and the list of Directors became more and more impressive. In addition to myself as President and Dr. Jay Sanford as Vice- President, other Directors included Floyd Denny, MD, Maxwell Finland, MD, Dorothy Horstmann, MD, Thomas Hunter, MD, George Jackson, MD, Smith Shadomy, PhD, John Sherris, MD, John Utz, MD, John Warner, MD, Dennis Watson, PhD, and Paul Wehrle, MD. An outstanding group, to say the least.

In addition, we began to build a Board of Trustees. Initially, this consisted of John Slater, Chair and President of Slater Food Service Management and T. Edward Temple, President of Virginia Commonwealth University. In the years to follow, we expanded the Board of Trustees considerably and added Berton Roueche (staff writer for The New Yorker, author of the famous book “Eleven Blue Men,” and twice recipient of the Lasker Journalism Award), Arthur Ashe (winner of the US Open and Wimbledon tennis championships), Dr. James Steele of veterinary and public health fame (and father of a new idea in medicine, referred to as “One Health Initiative”), the Honorable Paul Rogers (a well-known and long-standing congressman from Florida), Eugene Step (president of the Pharmaceutical Division of Eli Lilly), and Dave Butts (arguably the most famous Washington Redskin lineman who ever played NFL football and a winner of three Superbowl rings).

Re-elections for the position of NFID President were held every 3 years, and thus my term extended over 14 years, from 1976 to 1990, after which I served as Executive Director from 1991 through 1995. During all this time, many interesting and important things happened as NFID grew.

In 1976, during President Gerald Ford’s administration, swine flu became a threat in the US. Influenza vaccine was hurriedly made and widely distributed, the Guillain-Barré syndrome reared its ugly head, and people everywhere became frightened about vaccines and their usage. Virtually no one would stand up and preach the importance of vaccination. Even the government seemed to have run for cover. However, NFID proudly stepped up to the plate and did its best to encourage the public not to surrender.

Since that time, multiple national conferences on influenza and other vaccines were held, and every year afterwards NFIDNFID flu and pneumo urged the timely use of influenza vaccines and, when necessary, prescription flu medications, stressing the importance of prevention or early treatment of the disease.

In 1979, NFID first began to raise money for Young Investigator Research Grants. Eleven of 30 applicants received $4,000 each; in 1981, 4 of 14 applicants were each given $14,000 stipends. This philanthropy continued over the years.

In 1980, co-sponsored  by the Centers for Disease Control and Prevention (CDC), NFID undertook organizing the Second Decennial International Conference on Nosocomial Infections, a 5 day conference held in Atlanta. This conference, held every 10 years, proved to be very well received; and 10 years later in 1990, NFID and CDC sponsored the Third Decennial International Nosocomial Conference, with many physicians and nurses from throughout the world in attendance.

On January 3, 1985, NFID was delighted to receive a personally signed, full page letter from President Ronald Reagan lauding NFID for the great job it was doing in alerting the US population about pneumonia and influenza and encouraging the use of  vaccines for protection. Later that same year on November 21, NFID hosted a press conference in Washington, DC on influenza/pneumonia, involving some of the leading scientists and physicians in the country: namely, Dr. James Wynngaarten, Director of the National Institutes of Health (NIH); Dr. Anthony Fauci, Director of NIAID; and Dr. David Fedson, Head of the Division of Medicine at the University of Virginia. At the conference, Dr. Wyngaarten strongly endorsed the adult immunization program of NFID.

In 1988, NFID introduced its first annual Maxwell Finland Award, honoring Surgeon General C. Everett Koop as the first ever recipient. In the same year, NFID worked with CDC to create a coalition of 65 organizations in support of the Surgeon General’s goals for increasing the use of adult immunizations. Walter Orenstein, MD (NFID’s current President-Elect) worked with us on this campaign, contributing significantly to its success. It was then that Congress acted, as Medicare first began to pay for flu shots (insurance would not), and Congress passed legislation declaring the week of October 24th as National Adult Immunization Awareness Week.

The following year, in 1989, NFID and the American Society of Microbiology (ASM), developed and conducted the 4th National Forum on AIDS and Hepatitis B in Washington, DC, with over 500 scientists in attendance. Dr. Louis Sullivan, Secretary of Health and Human Services, gave the opening keynote address. This was followed a year later with the 5th National Forum on AIDS, Hepatitis, and Blood-Borne Diseases, in Atlanta, conducted by NFID, CDC, and NIAID.

In 1993, President Clinton commended NFID for recognizing July 27th as National Hepatitis Prevention Day. Dr. Ruth Westheimer, who was considered America’s premiere sex educator, launched a nationwide television public service program on behalf of NFID, as we had revealed that only 12% of the US population knew that hepatitis B could be contracted through sexual activity. Since hepatitis B frequently struck adolescents and young adults age 15 to 39 years, NFID concentrated on a nationwide teaching program for college students about hepatitis B infections and the approved vaccine. Dr. Ruth and I addressed over 400 college editors. Afterwards, when these students returned to their institutions, many of them published articles expressing the importance of hepatitis B prevention in their school newspapers. Also, we convinced health directors at more than 100 colleges to join the Hepatitis B Campus Prevention Program.

During all this time from 1981 on, NFID like many other organizations needed additional funding. Monies were secured through NFID sponsorship of many benefit golf tournaments wherever and whenever infectious disease people were having their meetings, including those sponsored by the Infectious Diseases Society of America (IDSA) and/or Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). This worked well; so that before each event, 50 to 60 or more doctors and/or researchers would play and each would contribute $250. In addition, many pharmaceutical and medical corporations also contributed to these tournaments and to our cause. In time, NFID held a total of 15 benefit tournaments. To this day, when I meet someone at ICAAC or IDSA, they still rush up to me and ask, “Dick, when are we going to have another golf tournament?”

After my retirement in 1995, I continued to enjoy serving and contributing to NFID. I’ve been with many of you and the organization continuously for 40 plus years, more than half my life, and I’ve enjoyed every minute of it. I believe NFID is a wonderful organization whose skills and contributions are badly needed by mankind. NFID has come a long way, and I believe it will march much further. It is still in its early stages of development.

Again, I sincerely thank you and all those who work for NFID, for taking time to listen to me and presenting me with the 2015 John P. Utz Leadership Award, which I shall cherish forever.

Richard J. Duma, MD, PhD
May 5, 2015
Bethesda, MD

To join the conversation, follow us on Twitter (@nfidvaccines) and use the hashtag #NFIDawards, like us on Facebook, join the NFID Linkedin Group, and subscribe to NFID Updates.